Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14954-2 Xylose^post dose PO SRat Urine 5H Qn     ACTIVE Xylose [Moles/time] in 5 hour Urine --post dose PO   MIN DefinitionDescription     mmol/5 H             CHAL   14954-2         Observation       0 Xylose p PO 5h Ur-sRate       Y   5 hours; 5.0Hr; 5HR; After; CHEMISTRY.CHALLENGE TESTING; D-xylose; p dose; p PO; PST; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn; Xylose absorption test 2.4 1.0k               mmol/(5.h)       0
14955-9 Zinc SCnc Ser/Plas Pt Qn     ACTIVE Zinc [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14955-9         Both       0 Zinc SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zn 2.73 1.0k               umol/L       0
14956-7 Albumin MRat Urine 24H Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin [Mass/time] in 24 hour Urine   MIN DefinitionDescription     ug/24 H             CHEM   14956-7   Detection limit <= 20 mg/L     Both       0 Microalbumin 24h Ur-mRate       Y   1 day; 24 hours; 24HR; Alb; Chemistry; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; Urn 2.73 1.0k               mg/(24.h)       0
14957-5 Albumin MCnc Urine Pt Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin [Mass/volume] in Urine   MIN DefinitionDescription     mg/L;mcg/mL; mg/dL             CHEM   14957-5   Detection limit <= 20 mg/L     Both       0 Microalbumin Ur-mCnc       Y   Alb; Chemistry; DL=20 mg/L; Kidney; Left; Level; Levo; MA; Malb; Mass concentration; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UniversalLabOrders; UR; Urn 2.73 1.0k               ug/mL;mg/dL       0
14958-3 Albumin/Creatinine MRto Urine 24H Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine   MIN DefinitionDescription     mg/g creatinine             CHEM   14958-3   Detection limit <= 20 mg/L     Both       0 Microalbumin/Creat 24h Ur       Y   1 day; 24 hours; 24HR; Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass concentration ratio; Mass ratio; MCRto; Micro albumin; Microalbumin; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UCr; UR; Urn 2.73 1.0k               mg/g{creat}       0
14959-1 Albumin/Creatinine MRto Urine Pt Qn Detection limit <= 20 mg/L   ACTIVE Microalbumin/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     mg/g creatinine             CHEM   14959-1   Detection limit <= 20 mg/L     Both       0 Microalbumin/Creat Ur       Y   Alb; Chemistry; CR; Crea; Creat; DL=20 mg/L; Kidney; Left; Levo; MA; Malb; Mass concentration ratio; Mass ratio; MCRto; Micro albumin; Microalbumin; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; UA; UCr; UR; Urn 2.73 1.0k               mg/g{creat}       0
1496-9 Glucose^1.5H post 75 g glucose PO MCnc Ser/Plas Pt Qn     ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO   MIN DefinitionDescription     mg/dL             CHAL   1496-9         Observation       0 Glucose 1.5h p 75 g Glc PO SerPl-mCnc       Y   1 1/2 hours; 1 1/2 HR; 1.5h p 75 g Glc PO; 1.5Hr; 75Gm; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1               mg/dL       0
14960-9 Estradiol.free/Estradiol.total MFr Ser/Plas Pt Qn     ACTIVE Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma   MIN DefinitionDescription     %             CHEM   14960-9         Observation       0 Estradiol Free MFr SerPl       Y   17-beta estradiol; Chemistry; E2; Estradiol Free; Estradiol.non-protein bound; FR; Gyn; Gynecology; Mass Fraction; Non-protein bound; OB; ObGyn; Obstetrics; Oestradiol; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k               %       0
14961-7 Abnormal blood cells.CD10/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD10 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14961-7         Observation       0 CD10 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CALLA; CD10 Abn Bld Cells; CD10 Cells; Cell; CELL MARKERS; Cellularity; Common acute lymphoblastic leukemia; Common acute lymphoblastic leukemia antigen; Enkephalinase; gp100; J5; NEP; Neprilysin; Neutral endopeptidase metalloendopeptidase; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14962-5 Abnormal blood cells.CD13/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD13 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14962-5         Observation       0 CD13 Abn Bld Cells NFr       Y   abn; abnorm; Aminopeptidase n; APN; Blood; CD13 Abn Bld Cells; CD13 Cells; Cell; CELL MARKERS; Cellularity; gp150; LeuM7; Leu-M7; My7; My-7; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14963-3 Abnormal blood cells.CD14/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD14 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14963-3         Observation       0 CD14 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CD14 Abn Bld Cells; CD14 Cells; Cell; CELL MARKERS; Cellularity; LeuM3; Leu-M3; LPS receptor; LPS-R; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14964-1 Abnormal blood cells.CD19/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD19 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14964-1         Both       0 CD19 Abn Bld Cells NFr       Y   abn; abnorm; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Abn Bld Cells; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.73 1.0k               %       0
14965-8 Abnormal blood cells.CD2/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD2 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14965-8         Observation       0 CD2 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CD2 Abn Bld Cells; CD2 Cells; CD2R; Cell; CELL MARKERS; Cellularity; E-rosette receptor; Leu5; Leu-5; LFA-2; Lymphocyte-function antigen-2; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T11; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14966-6 Abnormal blood cells.CD20/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD20 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14966-6         Observation       0 CD20 Abn Bld Cells NFr       Y   abn; abnorm; B1; B-1; Blood; Bp35; CD20 Abn Bld Cells; CD20 Cells; Cell; CELL MARKERS; Cells.CD20+; Cellularity; Leu16; Leu-16; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14967-4 Abnormal blood cells.CD33/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD33 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14967-4         Observation       0 CD33 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CD33 Abn Bld Cells; CD33 Cells; Cell; CELL MARKERS; Cellularity; gp67; LeuM9; Leu-M9; My9; My-9; Number fraction; p67; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood 2.7 1.0k               %       0
14968-2 Abnormal blood cells.CD5/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD5 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14968-2         Observation       0 CD5 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CD5 Abn Bld Cells; CD5 Cells; Cell; CELL MARKERS; Cellularity; Leu1; Leu-1; Ly-1; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T1; Tot; Totl; Tp67; WB; Whole blood 2.7 1.0k               %       0
14969-0 Abnormal blood cells.CD7/Abnormal blood cells.total NFr Bld Pt Qn     ACTIVE CD7 Abnormal blood cells/Abnormal blood cells.total in Blood   MIN DefinitionDescription     %             CELLMARK   14969-0         Observation       0 CD7 Abn Bld Cells NFr       Y   abn; abnorm; Blood; CD7 Abn Bld Cells; CD7 Cells; Cell; CELL MARKERS; Cellularity; gp40; Leu9; Leu-9; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T-2; Tot; Totl; TP41; WB; Whole blood 2.7 1.0k               %       0
1497-7 Glucose^1.5H post dose insulin IV MCnc Ser/Plas Pt Qn     ACTIVE Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV   MIN DefinitionDescription     mg/dL             CHAL   1497-7         Observation       0 Glucose 1.5h p Ins IV SerPl-mCnc       Y   1 1/2 hours; 1 1/2 HR; 1.5h p Ins IV; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; HUM; Humulin; IH7; Insul; Lente; Level; Mass concentration; NPH; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente 2.73 1               mg/dL       0
14970-8 Estrone.bioavailable MCnc Ser/Plas Pt Qn     ACTIVE Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     pg/mL             CHEM   14970-8         Both       0 Estrone Bioavail SerPl-mCnc       Y   Chemistry; E1; Estrone Bioavail; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k               pg/mL       0
14971-6 Estrone.bioavailable/Estrone.total MFr Ser/Plas Pt Qn     ACTIVE Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma   MIN DefinitionDescription     %             CHEM   14971-6         Observation       0 Estrone Bioavail MFr SerPl       Y   Chemistry; E1; Estrone Bioavail; Gyn; Gynecology; Mass Fraction; OB; ObGyn; Obstetrics; Percent; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tot; Totl 2.73 1.0k               %       0
14972-4 Mycobacterium sp DNA PrThr CSF Pt Ord Probe.amp.tar   ACTIVE Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by NAA with probe detection   MIN DefinitionDescription                   MICRO   14972-4   Probe.amp.tar     Both       0 Mycobacterium DNA CSF Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Myco; Mycobact; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tuberculosis 2.63 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14973-2 Mycobacterium sp DNA PrThr Sputum Pt Ord Probe.amp.tar   ACTIVE Mycobacterium sp DNA [Presence] in Sputum by NAA with probe detection   MIN DefinitionDescription                   MICRO   14973-2   Probe.amp.tar     Both       0 Mycobacterium DNA Spt Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lower respiratory; Lung; Microbiology; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Screen; SDA; species; spp; Spt; Sputum; Strand Displacement Amplification; TMA; Transcription mediated amplification; Tuberculosis 2.73 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14974-0 Mycobacterium sp DNA PrThr XXX Pt Ord Probe.amp.tar   ACTIVE Mycobacterium sp DNA [Presence] in Specimen by NAA with probe detection   MIN DefinitionDescription                   MICRO   14974-0   Probe.amp.tar     Both       0 Mycobacterium DNA Spec Ql NAA+probe           3 Self-Sustaining Sequence Replication; 3SR SR; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Myco; Mycobact; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Tuberculosis; Unspecified 2.73 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14975-7 Human antimouse Ab MCnc Ser Pt Qn     ACTIVE Human antimouse Ab [Mass/volume] in Serum   MIN DefinitionDescription     ng/mL             SERO   14975-7         Both       0 Human Antimouse Ab Ser-mCnc       Y   ABS; Aby; Antby; Anti; Antibodies; Antibody; Anti-Mouse; Autoantibodies; Autoantibody; HAMA; Human Anti-monoclonal AB; Human anti-mouse Ab; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR 2.73 1.0k               ng/mL       0
14976-5 Lecithin/Sphingomyelin Ratio Amnio fld Pt Qn     ACTIVE Lecithin/Sphingomyelin [Ratio] in Amniotic fluid   MIN DefinitionDescription     ratio             CHEM   14976-5         Both       0 Lecithin/Sphingomyelin Amn-Rto       Y   AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; c470; Chemistry; Choline phosphoglyceride; Phosphatidylcholine; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SPH; UniversalLabOrders 2.73 1.0k               {ratio}       0
104,672 results found